BIO-RAD LABORATORIES, INC. cotiza a 364.42 USD y tiene una capitalización bursátil de $9.7B. En los últimos 12 meses ha facturado $2.6B con un margen de flujo de caja libre del 14.5%. Cotiza a 27.6 veces su flujo de caja libre (P/FCF) y a un PER de 43.8. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactur…
| Periodo | 2026-10 | 2026-08 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.62 | $1.89 | $2.51 |
| Estimado | $2.23 | $1.75 | $1.99 | $2.70 |
| Sorpresa | — | +49.7% | -5.0% | -7.0% |
| Métrica | BIO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 51.9% | 57.0% | -5.2% |
| Operating Margin | 1.8% | -38.6% | +40.4% |
| Net Margin | 29.4% | -33.6% | +63.0% |
| FCF Margin | 14.5% | -13.9% | +28.4% |
| ROE | 10.2% | -40.4% | +50.6% |
| ROA | 7.2% | -32.0% | +39.2% |
| Current Ratio | 5.62 | 2.84 | +2.78 |
| Debt / Equity | 0.16 | 0.28 | -0.12 |